Johnson and Johnson News

Johnson & Johnson said Friday it completed its $893.7 million acquisition of Cougar Biotechnology Inc., a development stage company that is testing a potential vaccine for prostate cancer.

Jul 10, 2009 - Vertex Pharmaceuticals Incorporated today announced its intention to sell the rights to certain milestone payments tied to the future regulatory filing, approval and market launch of its hepatitis C virus protease inhibitor drug candidate, telaprevir, in Europe.

Oil prices hovered just above $60 a barrel Friday in Asia as investors braced for a slew of company earnings reports next week that will provide clues on the strength of crude demand.

Tonight in London before a lively saleroom, Sothebya TMs sales of Old Master Paintings and Renaissance & Baroque Masterworks from the Collection of Barbara Piasecka Johnson brought a combined total of A 36,022,625/ $57,917,177/ a 41,645,761 , a strong figure comfortably within the pre-sale expectations for the evening of A 29,222,500-42,470.000.

MCD , KO , MSFT , LLY , PFE , JNJ MCD , KO , MSFT , LLY , PFE , JNJ Warren Buffett is the richest investor in the world.

The $1.7 billion verdict against Abbott Laboratories last week is the latest evidence that the drug industry needs to heal itself by steering away from the me-too rut where resources, time and health are wasting away.

CEO Kelly Martin deserves praise for shepherding last week's deal with Johnson & Johnson that puts the Irish drugmaker on firmer financial footing.

The Vistakon division of Johnson & Johnson Vision Care today named Dave Brown president, Vistakon Americas, responsible for Vistakon's U.S. and Canadian businesses.

A a oeseemingly happy and successfula Wandsworth woman committed suicide after taking a cocktail of prescription drugs, an inquest heard on Tuesday.

Stock markets rewarded companies such as Johnson & Johnson and Cisco who were brave enough to make acquisitions in the months after Lehman Brothers' collapse, a study released on Monday showed.

Johnson & Johnson a s 50-year-old painkiller Tylenol should have lower doses to prevent liver injury, a U.S. panel said.

While politicians debate the future of the nationa s health-care system, one fund manager says there is no debating the growth potential of large-cap, medical technology firm Becton, Dickinson and Company .

Cougar Biotechnology, Inc. announced today that the initial offering period of Johnson & Johnson's tender offer for all the outstanding shares of Cougar common stock expired at midnight on July 2, 2009.

From a post by Joe Mullin: Centocor v. Abbott: Biggest Patent Verdict Ever. : This afternoon, a jury in Marshall, Texas, awarded the largest patent verdict in history: Abbott Laboratories must pay $1.67 billion to Centocor, a subsidiary of Johnson & Johnson, because its Humira arthritis treatment infringes U.S. Patent No.

American depositary receipts of the Irish biotech surged 8.6% on news that it agreed to sell its Alzheimer's immunotherapy program assets to Johnson & Johnson for a $1 billion investment.

Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr.

Johnson & Johnson will take an 18.4 percent stake in Ireland-based drug developer Elan Corp.

It is one of the world's most popular drugs, considered safe to treat fevers in children and aches and pains in pregnant women.

The U.S. District Court in Marshall, Texas, ordered Abbott Laboratories to pay Johnson & Johnson $1.7 billion in patent-related damages.

The FDA has publicly released documents from science reviewers expressing concern over the blood-thinning drug rivaroxaban, marketed by Bayer AG and Johnson & Johnson as Xarelto in Canada and Europe.